OncoGenex Pharma (OGXI) Reports In-Line Q1 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
OncoGenex Pharmaceuticals, Inc. Reports Financial Results for First Quarter 2016
May 12, 2016 4:01 PM EDTBOTHELL, Wash. and VANCOUVER, British Columbia, May 12, 2016 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced its first quarter 2016 financial results and provided a summary of anticipated milestones. Â
Financial Results and Anticipated Near-term Milestones
As of March 31, 2016, the company's cash, cash equivalents, and short-term investments were $46.1 million compared with $55.2 million as of December 31, 2015.
Based on current expectations, OncoGenex believes that its cash, cash equivalents, and short-term investments will be sufficient to fund its currently planned operations into the third quarter of 2017. Depending on timing of enrollment or event-driven... More
